For the quarter ending 2025-09-30, MGNX made $72,839K in revenue. $16,834K in net income. Net profit margin of 23.11%.
| Income Statement | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-09-30 |
|---|---|---|---|---|
| Total revenues | 72,839 | 22,241 | 13,192 | 110,708 |
| Cost of product sales | 0 | 0 | - | 168 |
| Cost of manufacturing services | 11,589 | 8,906 | 5,400 | 1,702 |
| Research and development | 32,709 | 40,791 | 39,698 | 40,543 |
| Selling, general and administrative | 9,905 | 9,302 | 10,718 | 14,104 |
| Total costs and expenses | 54,203 | 58,999 | 55,816 | 56,517 |
| Income (loss) from operations | 18,636 | -36,758 | -42,624 | 54,191 |
| Interest and other income | 1,528 | 1,414 | 1,679 | 2,118 |
| Interest and other expense | 3,342 | 802 | 91 | - |
| Income (loss) before income taxes | 16,822 | -36,146 | - | - |
| Income tax provision | 0 | 105 | - | - |
| Net loss | 16,822 | -36,251 | -41,036 | 56,309 |
| Unrealized gain on investments | 12 | -6 | -5 | 38 |
| Comprehensive income (loss) | 16,834 | -36,257 | -41,041 | 56,347 |
| Basic net loss per common share (in usd per share) | 0.27 | -0.57 | -0.65 | 0.9 |
| Basic weighted average common shares outstanding (in shares) | 63,233,266 | 63,136,057 | 62,965,415 | 62,744,005 |
| Diluted net loss per common share (in usd per share) | 0.27 | -0.57 | -0.65 | 0.9 |
| Diluted weighted average common shares outstanding (in shares) | 63,283,624 | 63,136,057 | 62,965,415 | 62,865,841 |
MACROGENICS INC (MGNX)
MACROGENICS INC (MGNX)